Cerebrovascular disease treating drug

A cerebrovascular disease and drug technology, applied in the field of drugs for the treatment of cerebrovascular disease, can solve the problems of lack of treatment means and difficulty in obtaining satisfactory curative effect, and achieve the effects of promoting rehabilitation, improving blood rheology, and dilating cerebral blood vessels

Inactive Publication Date: 2016-05-04
匡永刚
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In most ischemic cerebrovascular diseases, the inevitable death of nerve cells is the main cause of difficulty in achieving satisfactory curative effect
For the sequelae of cerebrovascular disease, there is currently no effective treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0008] The medicine of the present invention can be made into three dosage forms, that is, Naosukang capsule, Naosukang acupoint patch, and Naosukang drug test.

[0009] The preparation method of Naosukang capsule of the present invention: take by weighing salvia miltiorrhiza, Chuanxiong, pangolin, sealwort, Atractylodes macrocephala, angelica, astragalus, notoginseng, cohosh, leech, earthworm, horn, scorpion and silkworm, their weight kilograms The numbers are 30, 12, 10, 15, 12, 15, 30, 6, 8, 3, 10, 15, 6, 9. First, decoct with water to extract, decoct for 2 hours for the first time, filter out the precipitate, and then decoct for the second time. Decoct for 1 hour each time, filter out the precipitate, combine the 2 filtrates, and concentrate to form a paste. At 70 degrees Celsius, the relative density of the paste is 1.28. Mix the ointment and alcohol with a purity of more than 95% to make an ethanol solution with an alcohol content of 60-70, stir well, let it stand for p...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a cerebrovascular disease treating drug, which is prepared from 5-30 parts by weight of salvia miltiorrhiza, 10-15 parts by weight of ligusticum chuanxiong hort, 9-15 parts by weight of pangolin, 10-15 parts by weight of polygonatum sibiricum, 9-15 parts by weight of atractylodes macrocephala, 10-15 parts by weight of angelica sinensis, 15-30 parts by weight of milkvetch root, 3-9 parts by weight of panax notoginseng, 6-9 parts by weight of rhizoma cimicifugae, 2.5-5 parts by weight of leech, 6-10 parts by weight of earthworm, 10-15 parts by weight of ox horn, 3-6 parts by weight of scorpion and 4.5-10 parts by weight of bombyx batryticatus. According to the present invention, the cerebrovascular disease treating drug has effects of blood circulation activating, blood stasis dissipating, meridian passage dredging, cerebral vessel expanding, blood circulation improving and blood rheology improving, is used for stroke caused by phlegm stagnation and collateral obstruction, and symptoms such as limb numbness, dizziness, speech disorder, twisted mouth and crooked tongue, dull appearance, hemiparalysis and sudden fainting, can further be used for ischemic cerebral embolism, cerebral vascular atherosclerosis and cerebral hemorrhage sequelae, and further has effects of cerebral blood flow recovering, paralysis rehabilitation promoting, and living quality improving.

Description

technical field [0001] The invention relates to a medicine capable of treating cerebrovascular diseases through three administration routes. Background technique [0002] Cerebrovascular disease is a common and frequently-occurring disease in neurology. 50-70% of the survivors are left with severe disabilities such as paralysis and aphasia, which brings a heavy burden to society and families. Cerebrovascular diseases are divided into ischemic and hemorrhagic. It belongs to the category of stroke, hemiplegia, and hemiplegia of the motherland's medicine. At present, the drugs for treating cerebrovascular diseases mainly include thrombolytics, anticoagulants, brain tissue protective agents, and brain metabolism drugs; Chinese medicine mostly uses oral decoctions or Chinese patent medicines (such as cerebral thrombosis tablets) for hemiplegia syndrome differentiation. Clinical applications have strict treatment "time windows" and contraindications, or the scope of treatment is...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8969A61K9/48A61K9/70A61K9/02A61P9/10A61P25/00A61P7/02A61K35/32A61K35/36A61K35/56A61K35/62A61K35/64
Inventor 匡永刚
Owner 匡永刚
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products